Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Larimar Therapeutics (LRMR) Amortization of Deferred Charges (2016 - 2017)

Historic Amortization of Deferred Charges for Larimar Therapeutics (LRMR) over the last 4 years, with Q3 2017 value amounting to $3000.0.

  • Larimar Therapeutics' Amortization of Deferred Charges fell 6666.67% to $3000.0 in Q3 2017 from the same period last year, while for Dec 2017 it was $13000.0, marking a year-over-year decrease of 6976.74%. This contributed to the annual value of $13000.0 for FY2017, which is 6976.74% down from last year.
  • As of Q3 2017, Larimar Therapeutics' Amortization of Deferred Charges stood at $3000.0, which was down 6666.67% from $3000.0 recorded in Q2 2017.
  • In the past 5 years, Larimar Therapeutics' Amortization of Deferred Charges ranged from a high of $17000.0 in Q3 2014 and a low of $3000.0 during Q2 2017
  • Over the past 4 years, Larimar Therapeutics' median Amortization of Deferred Charges value was $11000.0 (recorded in 2016), while the average stood at $11153.8.
  • Per our database at Business Quant, Larimar Therapeutics' Amortization of Deferred Charges soared by 4000.0% in 2015 and then crashed by 7272.73% in 2017.
  • Over the past 4 years, Larimar Therapeutics' Amortization of Deferred Charges (Quarter) stood at $10000.0 in 2014, then surged by 40.0% to $14000.0 in 2015, then fell by 28.57% to $10000.0 in 2016, then crashed by 70.0% to $3000.0 in 2017.
  • Its last three reported values are $3000.0 in Q3 2017, $3000.0 for Q2 2017, and $7000.0 during Q1 2017.